Senior insider sale
Chief Legal Officer at 4D MOLECULAR THERAPEUTICS, INC. — senior position signals high conviction
$229.1K
18.01K shares
What this filing means
BIZILY SCOTT plans to sell 18.01K shares of 4D MOLECULAR THERAPEUTICS, INC. valued at approximately $229.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001950047-26-008088
Officer· Chief Legal Officer
Since Mar 2022
18.01K
Shares to sell
$229.1K
Approx. market value
1.64K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/13/2026
1.64KTotal acquired1.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/13/2026 | Exercise of Stock Options Cash | 1.64K | — |
| Total | 1.64K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.57K
Market value
$91.9K
6/30/2026
—Completed
Units to sell
9.81K
Market value
$117.7K
6/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.64K
Market value
$19.4K
8/13/2026
Total
Units
18.01K
Value
$229.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2026 | 6.57K | $91.9K | — | Completed |
6/23/2026 | 9.81K | $117.7K | — | Completed |
| Planned — Approximate Date | ||||
8/13/2026 | 1.64K | $19.4K | NASDAQ | Planned |
| Total | 18.01K | $229.1K | ||